These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4728289)

  • 1. Inhibition of activated factor X-induced platelet aggregation: the role of heparin and the plasma inhibitor to activated factor X.
    Yin ET; Giudice LC; Wessler S
    J Lab Clin Med; 1973 Sep; 82(3):390-8. PubMed ID: 4728289
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of heparin on the neutralization of factor Xa and thrombin by the plasma alpha-2-globulin inhibitor.
    Yin ET
    Thromb Diath Haemorrh; 1975 Feb; 33(1):43-50. PubMed ID: 47195
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement-dependent and complement-independent interactions of bacterial lipopolysaccharides and mucopeptides with rabbit and human platelets.
    Semeraro N; Colucci M; Vermylen J
    Thromb Haemost; 1979 Apr; 41(2):392-406. PubMed ID: 112708
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.
    Basic-Micic M; Breddin HK
    Semin Thromb Hemost; 1993; 19 Suppl 1():22-8. PubMed ID: 8395725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis.
    Han P; Ardlie NG
    Br J Haematol; 1974 Jun; 27(2):253-72. PubMed ID: 4843673
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of thrombin on platelet accumulation on the vessel wall - influence of heparin and aspirin.
    Dejana E; Cazenave JP; Hatton MW; Richardson M; Groves HM; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1983 Aug; 50(2):567-71. PubMed ID: 6356454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of factor IX and factor X on blood platelets.
    Osterud B; Holm T; Prydz H
    Scand J Haematol; 1974; 13(3):161-5. PubMed ID: 4376261
    [No Abstract]   [Full Text] [Related]  

  • 9. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
    Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
    Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of Vipera aspis venom on blood clotting factors and platelets.
    Boffa MC; Josso F; Boffa GA
    Thromb Diath Haemorrh; 1972 Feb; 27(1):8-18. PubMed ID: 5064234
    [No Abstract]   [Full Text] [Related]  

  • 11. A modified two-stage assay method for tissue-thromboplastin (TPLN).
    Kale NR
    Thromb Diath Haemorrh; 1966 May; 15(3):403-12. PubMed ID: 4965683
    [No Abstract]   [Full Text] [Related]  

  • 12. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of human blood platelets by immune complexes in the sedimentation pattern test.
    Myllylä G
    Scand J Haematol Suppl; 1973; 19():1-56. PubMed ID: 4127837
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of clotting factors associated with blood platelets after gel filtration.
    Tangen O; Lestrup EB; Berman HJ
    Thromb Diath Haemorrh; 1973 Nov; 30(2):289-98. PubMed ID: 4773368
    [No Abstract]   [Full Text] [Related]  

  • 15. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets.
    Briedé JJ; Heemskerk JW; van't Veer C; Hemker HC; Lindhout T
    Thromb Haemost; 2001 Mar; 85(3):509-13. PubMed ID: 11307823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activation of the anticoagulant system by prethrombin 2, a thrombin precursor].
    Strukova SM; Umarova BA; Gribkova NN; Kudriashov BA
    Biull Eksp Biol Med; 1980 Mar; 89(3):270-2. PubMed ID: 6966943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggregation of blood platelets in vitro and its inhibition by coumarins].
    Cepelăk V; Roubal Z; Cepelăkovă H
    Cas Lek Cesk; 1971 Sep; 110(37):863-8. PubMed ID: 4938615
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on experimentally induced hypercoagulable state in rabbits.
    Izak G; Galewsky K
    Thromb Diath Haemorrh; 1966 Jul; 16(1):228-42. PubMed ID: 5989043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.